The Promise of Animal Testing Alternatives at the U.S. Food and Drug Administration and National Institutes of Health
NEJM AI · 2026
DOI: 10.1056/aipc2500587 ↗Kurz gefasst
Editorial in der Zeitschrift NEJM AI, 2026. Verfasst von Ricardo Scheufen Tieghi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Program Coordination, Planning, and Strategic Initiatives, National Institutes of Health, Bethesda, MD, USA. Hauptthemen laut MEDLINE: United States Food and Drug Administration, Animal Testing Alternatives, Drug Development. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 82 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Program Coordination, Planning, and Strategic Initiatives, National Institutes of Health, Bethesda, MD, USA.
- United States Food and Drug Administration, Silver Spring, MD, USA.
ORCID-Profile: Ricardo Scheufen Tieghi, Tracy Beth Høeg, Martin A Makary, Nicole Kleinstreuer
Zitieren
APA
Tieghi, R. S., Høeg, T. B., Makary, M. A., & Kleinstreuer, N. (2026). The Promise of Animal Testing Alternatives at the U.S. Food and Drug Administration and National Institutes of Health. NEJM AI. https://doi.org/10.1056/aipc2500587
Vancouver
Tieghi RS, Høeg TB, Makary MA, Kleinstreuer N. The Promise of Animal Testing Alternatives at the U.S. Food and Drug Administration and National Institutes of Health. NEJM AI. 2026. doi:10.1056/aipc2500587
BibTeX
@article{Tieghi2026,
author = {Tieghi, Ricardo Scheufen and Høeg, Tracy Beth and Makary, Martin A and Kleinstreuer, Nicole},
title = {The Promise of Animal Testing Alternatives at the U.S. Food and Drug Administration and National Institutes of Health},
journal = {NEJM AI},
year = {2026},
doi = {10.1056/aipc2500587}
}
EUVIMED